BioCentury | Mar 5, 2020
Management Tracks

Mott retires from NEA

...for $15.6 billion, and served as an EVP at AZ after the acquisition. Mott founded MedImmune Ventures...
BioCentury | May 16, 2016
Financial News

G1 Therapeutics completes venture financing

...Cowen Private Investments; Franklin Templeton; Rock Springs Capital; Eshelman Ventures; Hatteras Venture Partners; Lumira Capital; MedImmune Ventures...
BioCentury | May 12, 2016
Financial News

G1 raises $47M in C round

...Springs Capital also participated, as did existing investors Eshelman Ventures, Hatteras Venture Partners, Lumira Capital, MedImmune Ventures...
BioCentury | Oct 10, 2015
Company News

Roche to acquire Adheron

...less than $22 million since its founding in 2005. Its investors included Health Care Ventures; MedImmune Ventures...
BioCentury | Feb 9, 2015
Financial News

G1 Therapeutics completes venture financing

...million Investors: Eshelman Ventures; RA Capital Management; Lumira Capital; Tavistock Life Sciences; Hatteras Venture Partners; MedImmune Ventures...
BioCentury | Feb 6, 2015
Financial News

G1 Therapeutics raises $33M in B round

...and Tavistock Life Sciences' Boxer Capital also participated, as did existing investors Hatteras Venture Partners; MedImmune Ventures...
BioCentury | Sep 29, 2014
Product Development

An arresting development

...The company raised $12.5 million in October 2013 in a series A round led by MedImmune Ventures...
BioCentury | May 5, 2014
Company News

MacroGenics management update

...formerly VP of corporate development and ventures at AstraZeneca plc and chair of the pharma's MedImmune Ventures...
BioCentury | Nov 18, 2013
Financial News

Catabasis Pharmaceuticals completes venture financing

...11/15/13 Type: Venture financing Raised: $32.4 million Investors: Lightstone Ventures; SV Life Sciences; Clarus Ventures; MedImmune Ventures...
BioCentury | Nov 18, 2013
Finance

Lightstone's first

...crossover fund also joined all current investors in the round: SV Life Sciences, Clarus Ventures, MedImmune Ventures...
Items per page:
1 - 10 of 122
BioCentury | Mar 5, 2020
Management Tracks

Mott retires from NEA

...for $15.6 billion, and served as an EVP at AZ after the acquisition. Mott founded MedImmune Ventures...
BioCentury | May 16, 2016
Financial News

G1 Therapeutics completes venture financing

...Cowen Private Investments; Franklin Templeton; Rock Springs Capital; Eshelman Ventures; Hatteras Venture Partners; Lumira Capital; MedImmune Ventures...
BioCentury | May 12, 2016
Financial News

G1 raises $47M in C round

...Springs Capital also participated, as did existing investors Eshelman Ventures, Hatteras Venture Partners, Lumira Capital, MedImmune Ventures...
BioCentury | Oct 10, 2015
Company News

Roche to acquire Adheron

...less than $22 million since its founding in 2005. Its investors included Health Care Ventures; MedImmune Ventures...
BioCentury | Feb 9, 2015
Financial News

G1 Therapeutics completes venture financing

...million Investors: Eshelman Ventures; RA Capital Management; Lumira Capital; Tavistock Life Sciences; Hatteras Venture Partners; MedImmune Ventures...
BioCentury | Feb 6, 2015
Financial News

G1 Therapeutics raises $33M in B round

...and Tavistock Life Sciences' Boxer Capital also participated, as did existing investors Hatteras Venture Partners; MedImmune Ventures...
BioCentury | Sep 29, 2014
Product Development

An arresting development

...The company raised $12.5 million in October 2013 in a series A round led by MedImmune Ventures...
BioCentury | May 5, 2014
Company News

MacroGenics management update

...formerly VP of corporate development and ventures at AstraZeneca plc and chair of the pharma's MedImmune Ventures...
BioCentury | Nov 18, 2013
Financial News

Catabasis Pharmaceuticals completes venture financing

...11/15/13 Type: Venture financing Raised: $32.4 million Investors: Lightstone Ventures; SV Life Sciences; Clarus Ventures; MedImmune Ventures...
BioCentury | Nov 18, 2013
Finance

Lightstone's first

...crossover fund also joined all current investors in the round: SV Life Sciences, Clarus Ventures, MedImmune Ventures...
Items per page:
1 - 10 of 122